0001209191-22-048473.txt : 20220902
0001209191-22-048473.hdr.sgml : 20220902
20220902160532
ACCESSION NUMBER: 0001209191-22-048473
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220901
FILED AS OF DATE: 20220902
DATE AS OF CHANGE: 20220902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Henderson Molly
CENTRAL INDEX KEY: 0001363812
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 221225082
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (877) 742-8466
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-01
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001363812
Henderson Molly
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102
FLORHAM
NJ
07932
0
1
0
0
CFO and CBO
Common Stock
2022-09-01
4
A
0
7500
0.00
A
45500
D
Common Stock
338.86
I
By 401(k)
Represents restricted stock units ("RSUs") granted on September 1, 2022. Fifty percent (50%) of the total number of RSUs granted vest on each of March 1, 2023 and June 1, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Includes 338.86 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.
/s/ Larry Miller, Attorney-in-Fact for Molly Henderson
2022-09-02